Literature DB >> 17875380

Odor identification deficits in frontotemporal dementia: a preliminary study.

Nicole C R McLaughlin1, Holly James Westervelt.   

Abstract

Multiple neurodegenerative disorders (e.g. Alzheimer's disease, Dementia with Lewy bodies, Parkinson's disease, and Huntington's disease) show olfactory deficits. Olfactory functioning has not been well studied in frontotemporal dementia (FTD). In the current study, individuals with FTD, Alzheimer's disease (AD), and healthy elderly controls were compared using an odor identification task. Results showed significant differences in odor identification between individuals with FTD and the healthy elderly control group. There were no differences between the FTD and AD groups. Using a cut score of 8/12, discriminant function analysis showed that the overall classification rate for the FTD and control groups was 71.4%, with a sensitivity rate of 87.5% and a specificity rate of 65%. This preliminary research demonstrates olfactory deficits in FTD, which appear to be similar in magnitude to the olfactory deficits seen in AD.

Entities:  

Mesh:

Year:  2007        PMID: 17875380     DOI: 10.1016/j.acn.2007.07.008

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  15 in total

1.  Should olfactory dysfunction be used as a biomarker of Alzheimer's disease?

Authors:  Daniel W Wesson; Donald A Wilson; Ralph A Nixon
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

2.  Emotion recognition in objects in patients with neurological disease.

Authors:  Michelle N Shiota; Michaela L Simpson; Heidi E Kirsch; Robert W Levenson
Journal:  Neuropsychology       Date:  2019-09-02       Impact factor: 3.295

Review 3.  Olfactory dysfunction in dementia.

Authors:  Jorge Alves; Agavni Petrosyan; Rosana Magalhães
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

4.  The predictors of parent reported behaviors related to olfactory information processing in children with ADHD.

Authors:  Ahmad Ghanizadeh
Journal:  Psychiatry Investig       Date:  2010-05-04       Impact factor: 2.505

5.  Reward deficits in behavioural variant frontotemporal dementia include insensitivity to negative stimuli.

Authors:  David C Perry; Samir Datta; Virginia E Sturm; Kristie A Wood; Jessica Zakrzewski; William W Seeley; Bruce L Miller; Joel H Kramer; Howard J Rosen
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

6.  Intact global cognitive and olfactory ability predicts lack of transition to dementia.

Authors:  Davangere P Devanand; Seonjoo Lee; Jose A Luchsinger; Howard Andrews; Terry Goldberg; Edward D Huey; Nicole Schupf; Jennifer Manly; Yaakov Stern; William C Kreisl; Richard Mayeux
Journal:  Alzheimers Dement       Date:  2020-01-04       Impact factor: 21.566

7.  Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction.

Authors:  Katerina Markopoulou; Bruce A Chase; Piotr Robowski; Audrey Strongosky; Ewa Narożańska; Emilia J Sitek; Mariusz Berdynski; Maria Barcikowska; Matt C Baker; Rosa Rademakers; Jarosław Sławek; Christine Klein; Katja Hückelheim; Meike Kasten; Zbigniew K Wszolek
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240

8.  The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.

Authors:  Nolwen L Rey; Daniel W Wesson; Patrik Brundin
Journal:  Neurobiol Dis       Date:  2016-12-20       Impact factor: 5.996

Review 9.  The Olfactory System as Marker of Neurodegeneration in Aging, Neurological and Neuropsychiatric Disorders.

Authors:  Naina Bhatia-Dey; Thomas Heinbockel
Journal:  Int J Environ Res Public Health       Date:  2021-06-29       Impact factor: 3.390

10.  Progressive modulation of the human olfactory bulb transcriptome during Alzheimer´s disease evolution: novel insights into the olfactory signaling across proteinopathies.

Authors:  Mercedes Lachen-Montes; María Victoria Zelaya; Víctor Segura; Joaquín Fernández-Irigoyen; Enrique Santamaría
Journal:  Oncotarget       Date:  2017-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.